Applied Molecular Transport Stock EBITDA
Applied Molecular Transport fundamentals help investors to digest information that contributes to Applied Molecular's financial success or failures. It also enables traders to predict the movement of Applied Stock. The fundamental analysis module provides a way to measure Applied Molecular's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Applied Molecular stock.
Applied |
Applied Molecular Transport Company EBITDA Analysis
Applied Molecular's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Applied Molecular EBITDA | (127.22 M) |
Most of Applied Molecular's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Applied Molecular Transport is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Applied Molecular Transport reported earnings before interest,tax, depreciation and amortization of (127.22 Million). This is 114.5% lower than that of the Biotechnology sector and 227.02% lower than that of the Health Care industry. The ebitda for all United States stocks is 103.26% higher than that of the company.
Applied EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Applied Molecular's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Applied Molecular could also be used in its relative valuation, which is a method of valuing Applied Molecular by comparing valuation metrics of similar companies.Applied Molecular is currently under evaluation in ebitda category among its peers.
Applied Fundamentals
| Return On Equity | -1.58 | |||
| Return On Asset | -0.51 | |||
| Current Valuation | (5.88 M) | |||
| Shares Outstanding | 41.85 M | |||
| Shares Owned By Insiders | 21.35 % | |||
| Shares Owned By Institutions | 37.20 % | |||
| Number Of Shares Shorted | 292.87 K | |||
| Price To Book | 0.70 X | |||
| Gross Profit | (42.08 M) | |||
| EBITDA | (127.22 M) | |||
| Net Income | (126.33 M) | |||
| Cash And Equivalents | 95.83 M | |||
| Cash Per Share | 2.46 X | |||
| Total Debt | 36.12 M | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 6.25 X | |||
| Book Value Per Share | 0.40 X | |||
| Cash Flow From Operations | (93.9 M) | |||
| Short Ratio | 0.96 X | |||
| Earnings Per Share | (1.89) X | |||
| Price To Earnings To Growth | (0.01) X | |||
| Target Price | 1.0 | |||
| Number Of Employees | 13 | |||
| Beta | 2.29 | |||
| Market Capitalization | 11.01 M | |||
| Total Asset | 107.45 M | |||
| Retained Earnings | (365.97 M) | |||
| Working Capital | 48.93 M | |||
| Z Score | -7.95 | |||
| Net Asset | 107.45 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Applied Stock
If you are still planning to invest in Applied Molecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Molecular's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |